In 2018 Wu et al., enrolling 106 patients with T2DM and evaluating the association between serum GLP-1 concentration and mild cognitive function impairment in MCI, demonstrated that lower serum GLP-1 levels are correlated to cognitive dysfunction in patients with diabetes (134). This evidence concerns the gene GLP1R and diabetes mellitus.